Angiopoietin-like protein 2 as a potential biomarker for colorectal cancer

View Full Paper

Ask AI

Bookmark

Why the study?

Does serum ANGPTL2 serve as a viable biomarker for the detection of colorectal cancer compared to healthy controls and established biomarkers?

Structured PICO

Does serum ANGPTL2 serve as a viable biomarker for the detection of colorectal cancer compared to healthy controls and established biomarkers?

Population

Colorectal cancer (CRC) patients, healthy controls, and 7 CRC cell lines

Intervention

Measurement of serum angiopoietin-like protein 2 (ANGPTL2)

Comparator

Healthy controls (for serum levels); C-reactive protein and carbohydrate antigen 19-9 (for diagnostic performance)

Outcome

Serum levels of ANGPTL2 and its diagnostic performance for CRCsurrogate

Serum ANGPTL2 is elevated in colorectal cancer patients and may serve as a complementary biomarker for early detection alongside established markers.

No takes yet. Share an insight, caveat, or question.

ANGPTL2 may aid CRC detection; hypothesis-generating and requires validation before any clinical role.

Yoshinaga et al. (2015) studied this question.

View Full Paper

Ask AI

Bookmark